share_log

LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Market Cap Increased by CN¥813m, Insiders Receive a 29% Cut

LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Market Cap Increased by CN¥813m, Insiders Receive a 29% Cut

LBX 連鎖藥房股份公司(SHSE: 603883)的市值增加了8.13億元人民幣,內部人士獲得 29% 的削減
Simply Wall St ·  04/22 15:07

Key Insights

關鍵見解

  • Insiders appear to have a vested interest in LBX Pharmacy Chain's growth, as seen by their sizeable ownership
  • The top 3 shareholders own 53% of the company
  • 22% of LBX Pharmacy Chain is held by Institutions
  • 業內人士似乎對LBX Pharmacy Chain的增長有既得利益,從他們龐大的所有權來看
  • 前三名股東擁有公司53%的股份
  • LBX 連鎖藥房的 22% 由機構持有

If you want to know who really controls LBX Pharmacy Chain Joint Stock Company (SHSE:603883), then you'll have to look at the makeup of its share registry. We can see that individual insiders own the lion's share in the company with 29% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

如果你想知道誰真正控制着LBX藥房連鎖股份公司(SHSE: 603883),那麼你必須看看其股票登記處的構成。我們可以看到,個別內部人士擁有公司的大部分股份,所有權爲29%。也就是說,如果股票上漲,該集團將受益最大(如果股價下跌,則損失最大)。

As a result, insiders scored the highest last week as the company hit CN¥19b market cap following a 4.6% gain in the stock.

結果,內部人士上週得分最高,該公司的市值在股價上漲4.6%後達到190億元人民幣。

In the chart below, we zoom in on the different ownership groups of LBX Pharmacy Chain.

在下圖中,我們放大了LBX藥房連鎖店的不同所有權組。

ownership-breakdown
SHSE:603883 Ownership Breakdown April 22nd 2024
SHSE: 603883 所有權明細 2024 年 4 月 22 日

What Does The Institutional Ownership Tell Us About LBX Pharmacy Chain?

關於LBX連鎖藥房,機構所有權告訴我們什麼?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

機構投資者通常將自己的回報與常見指數的回報進行比較。因此,他們通常會考慮收購相關基準指數中包含的大型公司。

As you can see, institutional investors have a fair amount of stake in LBX Pharmacy Chain. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see LBX Pharmacy Chain's historic earnings and revenue below, but keep in mind there's always more to the story.

如您所見,機構投資者在LBX藥房連鎖店中擁有相當數量的股份。這意味着在這些機構工作的分析師已經看過這隻股票,他們很喜歡。但是就像其他人一樣,他們可能錯了。當多家機構擁有一隻股票時,總是存在處於 “擁擠交易” 的風險。當這樣的交易出錯時,多方可能會競相快速出售股票。對於沒有增長曆史的公司,這種風險更高。你可以在下面看到LBX Pharmacy Chain的歷史收益和收入,但請記住,故事總是有更多內容。

earnings-and-revenue-growth
SHSE:603883 Earnings and Revenue Growth April 22nd 2024
SHSE: 603883 收益和收入增長 2024 年 4 月 22 日

LBX Pharmacy Chain is not owned by hedge funds. Looking at our data, we can see that the largest shareholder is Zilong Xie with 28% of shares outstanding. With 22% and 3.2% of the shares outstanding respectively, Leader (Cayman Islands) Limited and Rongtong Fund Management Co. Ltd. are the second and third largest shareholders.

LBX藥房連鎖店不歸對沖基金所有。從我們的數據來看,我們可以看到最大的股東是謝子龍,已發行股份的28%。利達(開曼群島)有限公司和融通基金管理有限公司分別持有22%和3.2%的已發行股份。Ltd. 是第二和第三大股東。

After doing some more digging, we found that the top 3 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.

在進一步挖掘之後,我們發現前三名股東共同控制了公司一半以上的股份,這意味着他們擁有影響公司決策的巨大權力。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

雖然研究公司的機構所有權可以爲您的研究增加價值,但研究分析師的建議以更深入地了解股票的預期表現也是一種好做法。有相當數量的分析師在報道該股,因此了解他們對未來的總體看法可能很有用。

Insider Ownership Of LBX Pharmacy Chain

LBX 連鎖藥房的內部所有權

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

公司內部人員的定義可能是主觀的,並且在不同的司法管轄區之間確實有所不同。我們的數據反映了個人內部人士,至少涵蓋了董事會成員。管理層最終對董事會負責。但是,經理成爲執行委員會成員的情況並不少見,尤其是當他們是創始人或首席執行官時。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部所有權表明領導層像公司的真正所有者一樣思考時,內部所有權是積極的。但是,高度的內部所有權也可以賦予公司內部的一小部分人巨大的權力。在某些情況下,這可能是負面的。

Our most recent data indicates that insiders own a reasonable proportion of LBX Pharmacy Chain Joint Stock Company. It has a market capitalization of just CN¥19b, and insiders have CN¥5.5b worth of shares in their own names. That's quite significant. Most would be pleased to see the board is investing alongside them. You may wish to access this free chart showing recent trading by insiders.

我們最新的數據表明,內部人士擁有LBX連鎖藥房股份公司的合理比例。它的市值僅爲190億元人民幣,內部人士以自己的名義持有價值55億元人民幣的股票。這非常重要。大多數人會很高興看到董事會與他們一起投資。您不妨訪問這張顯示內部人士近期交易的免費圖表。

General Public Ownership

一般公有制

With a 26% ownership, the general public, mostly comprising of individual investors, have some degree of sway over LBX Pharmacy Chain. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

LBX Pharmacy Chain擁有26%的所有權,主要由個人投資者組成的公衆對LBX藥房連鎖店有一定程度的影響力。儘管這個群體不一定能做主,但它肯定會對公司的運作方式產生真正的影響。

Private Company Ownership

私人公司所有權

We can see that Private Companies own 23%, of the shares on issue. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

我們可以看到,私人公司擁有已發行股份的23%。僅憑這一事實很難得出任何結論,因此值得研究誰擁有這些私營公司。有時,內部人士或其他關聯方通過單獨的私人公司對上市公司的股份擁有權益。

Next Steps:

後續步驟:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Take risks for example - LBX Pharmacy Chain has 1 warning sign we think you should be aware of.

儘管值得考慮擁有公司的不同群體,但還有其他因素更爲重要。以風險爲例——LBX藥房連鎖店有1個我們認爲你應該注意的警告信號。

Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

歸根結底,未來是最重要的。您可以訪問這份關於公司分析師預測的免費報告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論